This week, the FDA labeled Draeger’s recall of some ventilators as Class I, the most serious kind.
Draeger issued a voluntary correction, not a product removal, of specific Carina sub-acute care ventilators. The company said clinicians may continue to use the devices with adult patients and are instructed not to use the devices with pediatric patients.
Draeger is recalling the Carina ventilators due to contaminants in the device’s airpath. The contaminants exceed acceptable levels if used by pediatric patients for more than 30 days. Draeger found polyether polyurethane during testing in the airpath of the Carina ventilator. This results in the emission of contaminant 1,3-Dichloropropan-2-ol, a potential carcinogen.
Continued use of the Carina ventilators in pediatric patients could result in serious adverse health consequences, including exposure to hazardous chemicals, toxic reactions and death.
The recall affects 703 devices with dis…